4/9/2026Gan & Lee Out-Licenses Bi-Weekly GLP-1 Candidate Bofanglutide to JW Ph...

4/9/2026Over Half of China-Listed Drugmakers Grow 2025 Profit as Innovation an...

4/9/2026Luye Advances Next-Gen Schizophrenia Candidate LY03020 Into Phase II i...

4/9/2026Syneron Emerges as a Macrocycle Powerhouse as Funding and AZ Deal Fuel...

4/9/2026CDE Issues New Clinical Evaluation Guideline for Drug Marketing Applic...

4/9/2026CDE Releases New Clinical Evaluation Guideline for IND Applications to...

4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...

4/9/2026China Backs Independent Pricing for Innovative Drugs in Landmark State...

4/8/2026Global Drugmakers Brace for Another Tough China Year as Beijing Intens...

4/8/2026Merck and Zhifei Shift to Demand-Based China Vaccine Supply Model as G...

4/8/2026NMPA Adopts ICH Q8, Q9 and Q10 Q&A (R5)

4/8/2026NMPA Adopts ICH M14 Guideline, Expanding China's Regulatory Framework ...

4/7/2026Adagene, Incyte Launch Clinical Collaboration to Advance Novel MSS Col...

4/7/2026Henlius Wins China IND Approval for HLX319, Advancing SC HER2 Breast C...

4/7/2026Chengdu NRT Closes CNY 1B Series E to Accelerate Radiopharma Commercia...

4/7/2026Kelun-Biotech and HBM's Atopic Dermatitis Bispecific Revealed as TSLP/...

4/7/2026Bayer Deepens China Innovation Push as Pharma Division Targets 30% Mar...

4/7/2026Aidea Wins China IND Clearance for Long-Acting HIV PrEP Candidate ACC0...

4/7/2026China NMPA Clears 17 Novel Drugs in First Quarter, Highlighting Sustai...

4/7/2026Pharma Bets Big on Chinese Drugmakers (The Wire China)

4/3/2026China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...

4/3/2026CDE Revises Drug R&D and Technical Review Communication Management Mea...

4/3/2026Abbisko Advances ABSK061 Into US Clinical Development for Achondroplas...

4/3/2026Earendil Advances AI-Designed TL1A Antibody Into Mid-Stage UC Trial

4/3/2026BDGene Secures Strategic Financing, Relocates Headquarters to Hangzhou...

4/3/2026Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...

4/3/2026XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...

4/3/2026Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...

4/3/2026Recent Executive Moves

4/3/2026Hengrui Unveils Promising Phase 1 Data for FIC Dual-Target Psoriasis A...

Page:11/836 Total number of articles:25069: [First][<<] [9] [10] [11] [12] [13] [>>] [End]